Cambridge biotech Alchemab has extended its Series A with a £25m British Business Bank investment, the lender’s largest in a life sciences company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results